Caricamento...
Healthcare utilization and steroid-refractory toxicities from immune checkpoint inhibitors
BACKGROUND: Anti-programmed death-1 (PD-1) agents have transformed the treatment of advanced melanoma and other cancers, but the rates of steroid-refractory toxicities and healthcare utilization are not well-described. We assessed these endpoints in melanoma patients treated with anti-PD-1 +/− ipili...
Salvato in:
| Pubblicato in: | Cancer |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6952563/ https://ncbi.nlm.nih.gov/pubmed/31580492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32542 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|